{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:01:41Z","timestamp":1780045301781,"version":"3.53.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR0169000"],"award-info":[{"award-number":["AR0169000"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR059646"],"award-info":[{"award-number":["AR059646"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.rdc.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:53:35Z","timestamp":1749599615000},"page":"397-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["New Insights into the Pathogenesis of Psoriatic Arthritis"],"prefix":"10.1016","volume":"51","author":[{"given":"Maria de la Luz","family":"Garcia-Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher T.","family":"Ritchlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamond R.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir","family":"Wechalekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.rdc.2025.05.001_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.32.3.181","article-title":"Familial occurrence of psoriatic arthritis","volume":"32","author":"Moll","year":"1973","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41584-022-00776-6","article-title":"Psoriatic arthritis from a mechanistic perspective","volume":"18","author":"Schett","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2025.05.001_bib4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/art.41765","article-title":"Moving the goalpost toward remission: the case for combination immunomodulatory therapies in psoriatic arthritis","volume":"73","author":"Scher","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2025.05.001_bib5","first-page":"1417","article-title":"Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines","volume":"33","author":"Kavanaugh","year":"2006","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-022-00874-5","article-title":"Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy","volume":"19","author":"Najm","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.001_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2008.089367","article-title":"Familial aggregation of psoriatic arthritis","volume":"68","author":"Chandran","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib8","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-018-06672-6","article-title":"Genetic signature to provide robust risk assessment of psoriatic arthritis development in PsOpatients","volume":"9","author":"Patrick","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaad.2020.08.060","article-title":"Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational studies","volume":"84","author":"Xie","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.rdc.2025.05.001_bib10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/acr.20496","article-title":"Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis","volume":"63","author":"Eder","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44346-6","article-title":"Integrated single-cell and spatial transcriptomics reveals heterogeneity of fibroblast and pivotal genes in psoriasis","volume":"13","author":"He","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"PsOpathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/09546634.2017.1422591","article-title":"A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12\/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis","volume":"29","author":"Bilal","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"330","key":"10.1016\/j.rdc.2025.05.001_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8996","article-title":"Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts","volume":"8","author":"Uluckan","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rdc.2025.05.001_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.rdc.2025.05.001_bib17","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.12659\/MSM.896827","article-title":"Elevated IL-23R expression and Foxp3+Rorgt+ cells in intestinal mucosa during acute and chronic colitis","volume":"22","author":"Yang","year":"2016","journal-title":"Med Sci Monit"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.001_bib18","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/jid.2013.526","article-title":"In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORgammat and IL-17","volume":"134","author":"Keijsers","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.001_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11926-012-0257-3","article-title":"Is psoriatic arthritis a result of abnormalities in acquired or innate immunity?","volume":"14","author":"Lories","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","article-title":"T(H)17 cell heterogeneity and its role in tissue inflammation","volume":"24","author":"Schnell","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2025.05.001_bib21","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3389\/fimmu.2018.01936","article-title":"Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: new biomarkers in PsA","volume":"9","author":"Frasca","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.immuni.2016.06.021","article-title":"Antimicrobial peptide LL37 and MAVS signaling drive interferon-beta production by epidermal keratinocytes during skin injury","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"issue":"7162","key":"10.1016\/j.rdc.2025.05.001_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.001_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/BOR.0000000000001064","article-title":"Pathogenesis of psoriatic arthritis: new insights from a bone marrow perspective","volume":"37","author":"Saeed","year":"2025","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.001_bib25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jaci.2024.09.005","article-title":"Trained innate immunity: concept, nomenclature, and future perspectives","volume":"154","author":"Netea","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J Clin Investig"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib27","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","article-title":"IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis","volume":"74","author":"Adamopoulos","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2025.05.001_bib28","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","article-title":"Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis","volume":"26","author":"Alivernini","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.rdc.2025.05.001_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103167","article-title":"IL-23 induces CLEC5A(+) IL-17A(+) neutrophils and elicit skin inflammation associated with psoriatic arthritis","volume":"143","author":"Furuya","year":"2024","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.rdc.2025.05.001_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41584-023-01009-0","article-title":"Innate immune memory in inflammatory arthritis","volume":"19","author":"Jeljeli","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2025.05.001_bib31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/ard.2005.050963","article-title":"Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment","volume":"65","author":"van Kuijk","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib32","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.rdc.2025.05.001_bib33","article-title":"Histopathology of psoriatic arthritis synovium-A narrative review","volume":"9","author":"Tenazinha","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/rheumatology\/kex517","article-title":"CD8+ T cells with characteristic T cell receptor beta motif are detected in blood and expanded in SF of ankylosing spondylitis patients","volume":"57","author":"Komech","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2025.05.001_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.973243","article-title":"TCR repertoire profiling revealed antigen-driven CD8+ T cell clonal groups shared in SF of patients with spondyloarthritis","volume":"13","author":"Komech","year":"2022","journal-title":"Front Immunol"},{"issue":"269","key":"10.1016\/j.rdc.2025.05.001_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.001_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-024-01107-7","article-title":"Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis","volume":"20","author":"Chang","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.001_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112514","article-title":"Psoriatic and rheumatoid arthritis joints differ in the composition of CD8+ tissue-resident memory T cell subsets","volume":"42","author":"Povoleri","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.rdc.2025.05.001_bib39","article-title":"From PsO to PsA: the role of T(RM) and Tregs in psoriatic disease, a systematic review of the literature","volume":"11","author":"Lobao","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.rdc.2025.05.001_bib40","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/art.41652","article-title":"Tissue-resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis","volume":"73","author":"Leijten","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"77","key":"10.1016\/j.rdc.2025.05.001_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq3254","article-title":"Local IL-23 is required for proliferation and retention of skin-resident memory T(H)17 cells","volume":"7","author":"Whitley","year":"2022","journal-title":"Sci Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2025.05.001_bib42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jid.2021.01.005","article-title":"Differential changes in inflammatory mononuclear phagocyte and T-cell profiles within psoriatic skin during treatment with guselkumab vs. Secukinumab","volume":"141","author":"Mehta","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.det.2024.02.014","article-title":"Prevention of psoriatic arthritis: the need for prospective studies","volume":"42","author":"Wu","year":"2024","journal-title":"Dermatol Clin"},{"issue":"9","key":"10.1016\/j.rdc.2025.05.001_bib44","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/jid.2014.146","article-title":"Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of PsOpatients","volume":"134","author":"Teunissen","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjd.12658","article-title":"Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin","volume":"170","author":"Dyring-Andersen","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.001_bib46","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib47","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.rdc.2025.05.001_bib48","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis SF","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2025.05.001_bib49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3389\/fimmu.2018.00985","article-title":"Human gammadelta T-cell control of mucosal immunity and inflammation","volume":"9","author":"McCarthy","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.rdc.2025.05.001_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fimmu.2020.00042","article-title":"Regulation of gammadelta T cell effector diversification in the thymus","volume":"11","author":"Parker","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.001_bib51","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ni.1717","article-title":"CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets","volume":"10","author":"Ribot","year":"2009","journal-title":"Nat Immunol"},{"issue":"13","key":"10.1016\/j.rdc.2025.05.001_bib52","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00018-012-1163-6","article-title":"Diversity of IL-17-producing T lymphocytes","volume":"70","author":"Kim","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.rdc.2025.05.001_bib53","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1038\/ncomms4986","article-title":"Differential developmental requirement and peripheral regulation for dermal Vgamma4 and Vgamma6T17 cells in health and inflammation","volume":"5","author":"Cai","year":"2014","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cei.12853","article-title":"Interleukin (IL)-9\/IL-9R axis drives gammadelta T cells activation in psoriatic arthritis patients","volume":"186","author":"Guggino","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/eji.200535243","article-title":"CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation","volume":"36","author":"Ottaviani","year":"2006","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2249.2002.01721.x","article-title":"CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis","volume":"127","author":"Koreck","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2025.05.001_bib57","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.001_bib58","article-title":"Psoriatic arthritis involving TMJ: a review on pathogenesis and consideration on eventual gender differences","volume":"12","author":"Bernardi","year":"2024","journal-title":"Dent J (Basel)"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.001_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052506","article-title":"Tight junctions as a key for pathogens invasion in intestinal epithelial cells","volume":"22","author":"Paradis","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/nyas.13418","article-title":"Biphasic influence of Staphylococcus aureus on human epidermal tight junctions","volume":"1405","author":"Basler","year":"2017","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib61","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2353\/ajpath.2009.080973","article-title":"Alteration of tight junction proteins is an early event in psoriasis: putative involvement of proinflammatory cytokines","volume":"175","author":"Kirschner","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2025.05.001_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2025.01.006","article-title":"Risk of developing psoriatic arthritis in patients with PsOinitiating treatment with different classes of biologics","author":"Gisondi","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"3 Pt B","key":"10.1016\/j.rdc.2025.05.001_bib63","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.rdc.2025.05.001_bib64","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11926-013-0377-4","article-title":"Mechanistic insights from animal models of PsOand psoriatic arthritis","volume":"15","author":"Weitz","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib65","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1172\/JCI133159","article-title":"KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease","volume":"130","author":"Billi","year":"2020","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1016\/j.rdc.2025.05.001_bib66","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/art.40657","article-title":"Microbiota-dependent involvement of Th17 cells in murine models of inflammatory arthritis","volume":"70","author":"Evans-Marin","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.001_bib67","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41590-020-0634-4","article-title":"Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation","volume":"21","author":"Razani","year":"2020","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2025.05.001_bib108","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI85738","article-title":"RAC1 activation drives pathologic interactions between the epidermis and immune cells","volume":"126","author":"Winge","year":"2016","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.001_bib68","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/jid.2014.426","article-title":"Psoriatic inflammation facilitates the onset of arthritis in a mouse model","volume":"135","author":"Yamamoto","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.001_bib69","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4049\/jimmunol.1003986","article-title":"IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass","volume":"187","author":"Adamopoulos","year":"2011","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.rdc.2025.05.001_bib109","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178213","article-title":"Psoriatic arthritis subtypes are phenocopied in humanized mice","volume":"9","author":"Ritchlin","year":"2024","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.001_bib70","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/ard-2022-223389","article-title":"Alterations in the cutaneous microbiome of patients with PsOand psoriatic arthritis reveal similarities between non-lesional and lesional skin","volume":"82","author":"Boix-Amoros","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with PsOat increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2025.05.001_bib72","first-page":"213","article-title":"Reducing the risk of developing psoriatic arthritis in patients with psoriasis","volume":"12","author":"Gisondi","year":"2022","journal-title":"PsO(Auckl)"},{"issue":"84","key":"10.1016\/j.rdc.2025.05.001_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq7991","article-title":"Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems","volume":"8","author":"Castillo","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.rdc.2025.05.001_bib74","article-title":"Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention","author":"Eder","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.42288","article-title":"Dysregulation of bile acids, lipids, and nucleotides in psoriatic arthritis revealed by unbiased profiling of serum metabolites","volume":"75","author":"Paine","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib76","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/art.27287","article-title":"Angiogenesis and blood vessel stability in inflammatory arthritis","volume":"62","author":"Kennedy","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib77","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/annrheumdis-2012-201978","article-title":"Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2","volume":"72","author":"Gao","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib78","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/ard.2006.062042","article-title":"Ectopic lymphoid neogenesis in psoriatic arthritis","volume":"66","author":"Canete","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2025.05.001_bib79","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ebiom.2019.07.032","article-title":"TCR repertoire and CDR3 motif analyses depict the role of alphabeta T cells in Ankylosing spondylitis","volume":"47","author":"Zheng","year":"2019","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib80","doi-asserted-by":"crossref","first-page":"R569","DOI":"10.1186\/ar1698","article-title":"Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis","volume":"7","author":"Kruithof","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.rdc.2025.05.001_bib81","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/annrheumdis-2021-221761","article-title":"Distinct stromal and immune cell interactions shape the pathogenesis of rheumatoid and psoriatic arthritis","volume":"81","author":"Floudas","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"10136","key":"10.1016\/j.rdc.2025.05.001_bib82","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.rdc.2025.05.001_bib83","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/17512433.2017.1329009","article-title":"Tumor necrosis factor inhibitors in psoriatic arthritis","volume":"10","author":"Mantravadi","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.rdc.2025.05.001_bib84","first-page":"1544","article-title":"Patterns of cytokine production in psoriatic synovium","volume":"25","author":"Ritchlin","year":"1998","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2025.05.001_bib85","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/rheumatology\/kew204","article-title":"Reduced CLEC9A expression in synovial tissue of psoriatic arthritis patients after adalimumab therapy","volume":"55","author":"Ramos","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.001_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054901","article-title":"Psoriatic arthritis: pathogenesis and targeted therapies","volume":"24","author":"Azuaga","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-021-00999-8","article-title":"Axial psoriatic arthritis","volume":"23","author":"Gladman","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib88","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2020.05.089","article-title":"Axial psoriatic arthritis: an update for dermatologists","volume":"84","author":"Gottlieb","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"Supplement_2","key":"10.1016\/j.rdc.2025.05.001_bib89","doi-asserted-by":"crossref","first-page":"ii15","DOI":"10.1093\/rheumatology\/keae558","article-title":"Axial involvement in psoriatic arthritis: is it unique?","volume":"63","author":"Helliwell","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.001_bib90","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.001_bib91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.1780140302","article-title":"Ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, PsOand Reiter\u2019s disease. A comparative study","volume":"14","author":"McEwen","year":"1971","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib92","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2025.05.001_bib93","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41584-023-01038-9","article-title":"Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis","volume":"19","author":"McGonagle","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.001_bib94","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/annrheumdis-2021-221422","article-title":"No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related \u2018physician-reported spondylitis\u2019","volume":"81","author":"Braun","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2025.05.001_bib95","article-title":"No significant effects of IL-23 on initiating and perpetuating the axial spondyloarthritis: the reasons for the failure of IL-23 inhibitors","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"issue":"Suppl 4","key":"10.1016\/j.rdc.2025.05.001_bib96","doi-asserted-by":"crossref","first-page":"iv28","DOI":"10.1093\/rheumatology\/keab617","article-title":"IL-23 and axial disease: do they come together?","volume":"60","author":"Mease","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.rdc.2025.05.001_bib97","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S2665-9913(21)00105-3","article-title":"Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies","volume":"3","author":"Mease","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib98","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s13063-022-06589-y","article-title":"Efficacy and safety of guselkumab in biologic-naive patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial","volume":"23","author":"Gladman","year":"2022","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.rdc.2025.05.001_bib99","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.20566","article-title":"The \u201centhesis organ\u201d concept: why enthesopathies may not present as focal insertional disorders","volume":"50","author":"Benjamin","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.001_bib100","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/kes384","article-title":"High-resolution [18F]fluoride positron emission tomography of the distal interphalangeal joint in psoriatic arthritis--a bone-enthesis-nail complex","volume":"52","author":"Tan","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.rdc.2025.05.001_bib101","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2018MHC-I-opathy\u2019-unified concept for spondyloarthritis and Behcet disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.001_bib102","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#","article-title":"Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy","volume":"41","author":"McGonagle","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib103","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/annrheumdis-2014-205839","article-title":"High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis","volume":"74","author":"Tan","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.001_bib104","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.41239","article-title":"Association of structural entheseal lesions with an increased risk of progression from PsOto psoriatic arthritis","volume":"74","author":"Simon","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.001_bib105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s42255-018-0016-5","article-title":"A network of trans-cortical capillaries as mainstay for blood circulation in long bones","volume":"1","author":"Gruneboom","year":"2019","journal-title":"Nat Metab"},{"issue":"12","key":"10.1016\/j.rdc.2025.05.001_bib106","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.001_bib107","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/s41467-018-06933-4","article-title":"Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis","volume":"9","author":"Cambre","year":"2018","journal-title":"Nat Commun"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X25000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X25000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:15:46Z","timestamp":1752711346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X25000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0889857X25000249"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2025.05.001","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights into the Pathogenesis of Psoriatic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}